54 results on '"K. Gorski"'
Search Results
2. Racial and Ethnic Disparities in Emergency Department Wait Times for Children: Analysis of a Nationally Representative Sample
- Author
-
Jillian K, Gorski, Elizabeth R, Alpern, Douglas J, Lorenz, and Sriram, Ramgopal
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
To evaluate the association of race and ethnicity with wait times for children in US emergency departments (ED).We performed a cross-sectional study of ED encounters of children (18 years) from 2014 to 2019 using a multistage survey of nonfederal US ED encounters. Our primary variable of interest was composite race and ethnicity: non-Hispanic White (NHW), non-Hispanic Black, Hispanic, and all others. Our outcome was ED wait time in minutes. We evaluated the association between race and ethnicity and wait time in Weibull regression models that sequentially added variables of acuity, demographics, hospital factors, and region/urbanicity.We included 163,768,956 survey-weighted encounters. In univariable analysis, Hispanic children had a lower hazard ratio (HR) of progressing to evaluation (HR 0.84, 95% confidence interval [CI] 0.76-0.93) relative to NHW children, indicating longer ED wait times. This association persisted in serial multivariable models incorporating acuity, demographics, and hospital factors. This association was not observed when incorporating variables of hospital region and urbanicity (HR 0.91, 95% CI 0.83-1.00). In subgroup analysis, Hispanic ethnicity was associated with longer wait times in pediatric EDs (HR 0.76, 95% CI 0.63-0.92), non-metropolitan EDs (HR 0.75, 95% CI 0.64-0.89), and the Midwest region (HR 0.77, 95% CI 0.69-0.87). No differences in wait times were observed for children of Black race or other races.Hispanic children experienced longer ED wait times across serial multivariable models, with significant differences limited to pediatric, metropolitan, and Midwest EDs. These results highlight the presence of disparities in access to prompt emergency care for children.
- Published
- 2023
- Full Text
- View/download PDF
3. The Impact of Emergency Department Census on the Decision to Admit.
- Author
-
Jillian K. Gorski, Robert J. Batt, Erkin Otles, Manish N. Shah, Azita G. Hamedani, and Brian W. Patterson
- Published
- 2016
4. PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study
- Author
-
N Tchao, N Sarkar, X Hu, R Zhang, C Milmont, Y Shi Jin, V Chow, M Kroenke, K Gorski, R Furie, K Alan, and C Stanley
- Published
- 2022
- Full Text
- View/download PDF
5. The Impact of Diagnostic Decisions on Patient Experience in the Pediatric Emergency Department
- Author
-
Eneida A. Mendonça, Cory Showalter, and Jillian K. Gorski
- Subjects
medicine.medical_specialty ,business.industry ,Psychological intervention ,Retrospective cohort study ,Context (language use) ,General Medicine ,Emergency department ,Odds ratio ,Logistic regression ,Patient Discharge ,Confidence interval ,Patient Outcome Assessment ,Pediatrics, Perinatology and Child Health ,Emergency medicine ,Patient experience ,Emergency Medicine ,medicine ,Humans ,Child ,Emergency Service, Hospital ,business ,Delivery of Health Care ,Retrospective Studies - Abstract
Objective Patient experience serves as both a subjective measure of value-based health care delivery and a metric to inform operational decision making. The objective of this study was to determine if specific diagnostic and therapeutic interventions affect patient experience scores for children seen in the emergency department. Methods We performed a retrospective observational study in the emergency department of a large quaternary care children's hospital on patients who were discharged to home and later completed a National Research Corporation Health patient experience survey. We matched the survey results to electronic health record (EHR) data and were able to extract demographics, operational metrics, and order information for each patient. We performed multiple logistic regression analyses to determine the association of image acquisition, laboratory test ordering, medication administration, and discharge prescribing with likelihood to recommend the facility as our measure of patient experience. Results Of the 4103 patients who met inclusion criteria for the study, 75% strongly recommended the facility. Longer wait times were associated with lower patient experience scores [odds ratio (OR) per waiting room hour increase, 0.72; 95% confidence interval (CI), 0.65-0.81]. Significant diagnostic factors associated with higher patient experience included magnetic resonance imaging ordering (OR, 2.38; 95% CI, 1.00-5.67), x-ray ordering (OR, 1.19; 95% CI, 1.00-1.42), and electrocardiogram ordering (OR, 1.62; 95% CI, 1.07-2.44). Of the treatment factors studied, only antibiotic prescribing at discharge was found to have a significant positive association with patient experience (OR, 1.32; 95% CI, 1.08-1.63). Conclusion The positive association between more intensive diagnostic workups and patient experience could have implications on the utility of patient experience scores to evaluate pediatric care teams. Consideration should be taken to interpret patient experience scores in the context of compliance with approaches in evidence-based medicine.
- Published
- 2021
- Full Text
- View/download PDF
6. EPConDB: a web resource for gene expression related to pancreatic development, beta-cell function and diabetes.
- Author
-
Joan M. Mazzarelli, John Brestelli, Regina K. Gorski, Junmin Liu, Elisabetta Manduchi, Deborah F. Pinney, Jonathan Schug, Peter White, Klaus H. Kaestner, and Christian J. Stoeckert Jr.
- Published
- 2007
- Full Text
- View/download PDF
7. A pilot to explore if of co-locating Advanced Practice Physiotherapists with Physiotherapists improves clinical knowledge and evidence based practice
- Author
-
K. Thomson, S. Cliffe, K. Dawson, K. Gorski, and P.K. Stevenson
- Subjects
Physical Therapy, Sports Therapy and Rehabilitation - Published
- 2022
- Full Text
- View/download PDF
8. 44P Biomarker analysis from a phase Ib, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into metastatic and primary liver tumors
- Author
-
J.R. Hecht, M. Peeters, M. Martin Jimenez, M. Pless, A. Cubillo, J. Garcia-Corbacho, N. Mach, A. Digklia, H. Park, V. Subbiah, K. Gorski, A. Anderson, C. Liu, W. Snyder, and J. Chesney
- Subjects
Oncology ,Hematology - Published
- 2021
- Full Text
- View/download PDF
9. AB0432 EFAVALEUKIN ALFA, A NOVEL IL-2 MUTEIN, SELECTIVELY EXPANDS REGULATORY T CELLS IN PATIENTS WITH SLE: FINAL RESULTS OF A PHASE 1B MULTIPLE ASCENDING DOSE STUDY
- Author
-
N. Tchao, N. Sarkar, X. Hu, R. Zhang, C. Milmont, Y. Shi Jin, V. Chow, M. Kroenke, K. Gorski, R. Furie, A. Kivitz, and S. Cohen
- Subjects
Rheumatology ,Immunology ,Immunology and Allergy ,General Biochemistry, Genetics and Molecular Biology - Abstract
BackgroundDefects in regulatory T cell (Treg) number and function are associated with autoimmune diseases including SLE. Interleukin (IL)-2 is essential for the development and suppressive function of Treg, and therapies that exploit the ability of IL-2 to expand Treg have shown disease-modifying potential in SLE1. However, low-dose IL-2 has a short half-life and narrow selectivity for Treg over conventional CD4+ T cells (Tcon) and natural killer (NK) cells. Efavaleukin alfa is an IL-2 mutein Fc fusion protein; an introduced mutation decreases binding to IL-2Rβ and increases dependence on IL-2Rα (CD25). This preferential binding to the high-affinity IL-2R, constitutively expressed at high levels on Treg, leads to increased cell surface retention and sustained Treg signaling compared with recombinant IL-2. In healthy subjects, a single dose of efavaleukin alfa was well tolerated and led to robust and selective Treg expansion2.ObjectivesThis final analysis of a phase 1b, double-blind, placebo-controlled, multiple ascending dose study (NCT03451422) reports the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic effects of efavaleukin alfa in patients with SLE.MethodsThe study included five ascending dose cohorts (cohort 1=lowest dose; cohort 5=highest dose). A total of 35 patients with SLE (age 24–71 years; 85.7% female; SLE diagnosed using SLICC or ACR criteria with ANA ≥1:80 and/or elevated anti-dsDNA antibodies) were randomized to receive efavaleukin alfa or placebo (5:2 ratio for cohorts 1–3; 3:1 ratio for cohorts 4–5) subcutaneously every 2 weeks (Q2W; cohorts 1, 2, 4, and 5) or every week (QW; cohort 3) in addition to standard of care therapy for a total of 12 weeks, with 6 weeks of follow-up. The primary endpoint was the incidence of treatment-emergent adverse events (TEAEs). Additional endpoints included serum PK of efavaleukin alfa and changes in numbers of Treg, CD4+ Tcon, CD8+ T cells, and NK cells in peripheral blood.ResultsThe most commonly reported TEAEs (occurring in ≥25% of efavaleukin alfa-treated subjects) included non-serious, mild or moderate (grade 1–2) injection site reactions. No grade 4 TEAEs or deaths occurred. Two serious AEs were reported in efavaleukin alfa-treated subjects: one event of syncope (grade 3) was observed in cohort 2 and was not considered related to treatment, and one case of eosinophilia (grade 2) was observed in cohort 5 and was considered related to treatment. Efavaleukin alfa PK was generally linear and dose-proportional, with a terminal half-life ranging from 18–30 hours. Peak Foxp3+ Treg expansion was observed at 8 days post-dose, and the magnitude of the peak was generally sustained after multiple QW or Q2W doses. The mean peak increases in Foxp3+ Treg were 14.8-, 17.4-, 5.7-, 2.4-, and 1.1-fold above baseline for efavaleukin alfa Q2W dosing cohorts 5, 4, 2, and 1 and placebo, respectively. At the final study assessment (42 days after the last dose), the mean Treg count was 1.3-fold above baseline (95% CI, 0.9–1.9). Treatment with efavaleukin alfa also expanded CD25bright Treg (peak 53.8-fold change) and CD31+ recent thymic emigrant (RTE), naïve, and memory Treg subsets. At the highest dose (cohort 5), low-level increases in numbers of CD4+ Tcon (peak 2.3-fold), CD8+ T cells (peak 2.1-fold), and NK cells (peak 2.9-fold) were observed.ConclusionMultiple ascending doses of efavaleukin alfa were safe and well tolerated and led to selective and prolonged Treg expansion in SLE patients. Results at the highest dose suggest a plateau in Treg expansion with low-level increases in other IL-2–responsive cells, although interpretation is limited due to small subject numbers. The highest tested dose may be outside the therapeutic window and thus will not be assessed in phase 2 clinical studies. These findings confirm and extend previous results in healthy subjects and support the ongoing phase 2b adaptive randomized controlled trial in patients with SLE.References[1]Humrich J. Arthritis Rheumatol. 2016;68 (suppl 10);2Tchao N. Blood. 2017;130 (suppl 1).AcknowledgementsFunding: Amgen IncDisclosure of InterestsNadia Tchao Shareholder of: Amgen Inc., Employee of: Amgen Inc., Nandita Sarkar Shareholder of: Amgen Inc., Employee of: Amgen Inc., Xuguang Hu Shareholder of: Amgen Inc., Employee of: Amgen Inc., Rong Zhang Shareholder of: Amgen Inc., Employee of: Amgen Inc., Cassandra Milmont Shareholder of: Amgen Inc., Employee of: Amgen Inc., Yan Shi Jin Shareholder of: Amgen Inc., Employee of: Amgen Inc., Vincent Chow Shareholder of: Amgen Inc., Employee of: Amgen Inc., Mark Kroenke Shareholder of: Amgen Inc., Employee of: Amgen Inc., Kevin Gorski Shareholder of: Amgen Inc., Employee of: Amgen Inc., Richard Furie Consultant of: Amgen Inc, Grant/research support from: Amgen Inc, Alan Kivitz Shareholder of: Amgen Inc., Gilead, GlaxoSmithKline, Novartis, Pfizer, and Sanofi, Speakers bureau: AbbVie, Celgene, Flexion, Genzyme, GSK, Horizon, Lilly, Merck, Novartis, Pfizer, Sanofi, and UCB, Consultant of: AbbVie, Boehringer Ingelheim, Flexion, Gilead, Janssen, Pfizer, Sanofi, and Sun Pharma, Stanley Cohen Consultant of: Amgen Inc., AbbVie, Eli Lilly, Pfizer, Genentech, and Gilead, Grant/research support from: Amgen Inc., AbbVie, Eli Lilly, Pfizer, Genentech, and Gilead
- Published
- 2022
- Full Text
- View/download PDF
10. Gonadotropin-releasing hormone and kisseptin-10 regulate nuclear receptor subfamily 5 group a member 1/catenin beta 1/ nuclear receptor subfamily 0 group B member 1 activity in female rat anterior pituitary gland
- Author
-
M, Zielinska-Gorska, K, Gorski, K, Biernacka, E, Sawosy, T, Kaminska, and A, Gajewska
- Subjects
Gonadotropin-Releasing Hormone ,Kisspeptins ,DAX-1 Orphan Nuclear Receptor ,Pituitary Gland, Anterior ,Animals ,Female ,Rats, Wistar ,Steroidogenic Factor 1 ,beta Catenin - Abstract
In this study, we tested the hypothesis that modulation of endogenous gonadotropin-releasing hormone (Gnrh) neuronal network activity alters the mRNA expression of nuclear receptor subfamily 5 group A member 1 (Nr5a1), through one of the component of Wnt pathway signaling - catenin beta 1 (Ctnnb1) (its co-activator), and its co-repressor nuclear receptor subfamily 0, group B member 1 (Nr0b1) in the female rat pituitary gland in vivo. Adult ovariectomized rats were given a serial infusion of Gnrh, kisspeptin-10, Gnrh + Gnrh antagonist (Antide), or kisspeptin-10 + kisspeptin antagonist (kisspeptin-234) into the third ventricle of the brain. The anterior pituitary and blood was used to mRNA and protein expression analysis. We demonstrated that Gnrh up-regulates Nr5a1 mRNA expression in the anterior pituitary and induces NR5A1 depletion in gonadotropes. Gnrh administration increased both Ctnnb1 mRNA expression and protein synthesis, and induced activation of cellular Ctnnb1 via translocation from the gonadotropes cytoplasm to nucleus. After kisspeptin-10 treatment, up-regulation of Nr0b1 mRNA and protein expression in the anterior pituitary was observed. These data indicate that Gnrh-neuron-mediated network activity alters Nr5a1 gene transcription and translation in gonadotrope cells and this effect may result from the changes induced in the Ctnnb1 and Nr0b1 gene/protein expression balance.
- Published
- 2018
11. Anesthésie-réanimation chez l’obèse
- Author
-
B. Vallet, G. Andrieu, F. Wierre, Gilles Lebuffe, V. Sanders, K. Gorski, and N. Chalons
- Subjects
business.industry ,Medicine ,Surgery ,business - Published
- 2010
- Full Text
- View/download PDF
12. Autologous Stem Cell Treatments for High Risk Neuroblastoma
- Author
-
K, Gorski, primary and VS, Gallicchio, additional
- Published
- 2018
- Full Text
- View/download PDF
13. EPConDB: a web resource for gene expression related to pancreatic development, beta-cell function and diabetes
- Author
-
Regina K. Gorski, Peter White, Elisabetta Manduchi, Christian J. Stoeckert, John Brestelli, Jonathan Schug, Joan M. Mazzarelli, Klaus H. Kaestner, Junmin Liu, and Deborah F. Pinney
- Subjects
Transcription, Genetic ,Microarray ,Biology ,Mice ,User-Computer Interface ,Diabetes mellitus genetics ,Insulin-Secreting Cells ,Databases, Genetic ,Genetic model ,Gene expression ,Diabetes Mellitus ,Genetics ,Transcriptional regulation ,Animals ,Humans ,Promoter Regions, Genetic ,Pancreas ,Gene ,Oligonucleotide Array Sequence Analysis ,Internet ,Binding Sites ,Gene Expression Profiling ,Articles ,DNA binding site ,Gene expression profiling ,Software ,Transcription Factors - Abstract
EPConDB (http://www.cbil.upenn.edu/EPConDB) is a public web site that supports research in diabetes, pancreatic development and beta-cell function by providing information about genes expressed in cells of the pancreas. EPConDB displays expression profiles for individual genes and information about transcripts, promoter elements and transcription factor binding sites. Gene expression results are obtained from studies examining tissue expression, pancreatic development and growth, differentiation of insulin-producing cells, islet or beta-cell injury, and genetic models of impaired beta-cell function. The expression datasets are derived using different microarray platforms, including the BCBC PancChips and Affymetrix gene expression arrays. Other datasets include semi-quantitative RT-PCR and MPSS expression studies. For selected microarray studies, lists of differentially expressed genes, derived from PaGE analysis, are displayed on the site. EPConDB provides database queries and tools to examine the relationship between a gene, its transcriptional regulation, protein function and expression in pancreatic tissues.
- Published
- 2007
- Full Text
- View/download PDF
14. Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies using Fak-deficient mice
- Author
-
K. Gorski, Megan E. Cosgrove, Michelle E. Roh, and Ian S. Hitchcock
- Subjects
Mice, Knockout ,biology ,Kinase ,Chemistry ,Integrin ,Hematology ,Pharmacology ,Platelet Activation ,Article ,Mice ,Thrombin ,Biochemistry ,Focal Adhesion Protein-Tyrosine Kinases ,biology.protein ,medicine ,Animals ,Platelet ,Artery occlusion ,Platelet activation ,biological phenomena, cell phenomena, and immunity ,Kinase activity ,Protein Kinase Inhibitors ,Platelet factor 4 ,medicine.drug - Abstract
Focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase critical in mediating adhesion and migration in many cell types via direct association with integrins. Considering its role in controlling events downstream of integrin activation, the function of FAK in platelet signaling has been well studied. Platelet adhesion to fibrinogen via integrin αIIbβ3 leads to rapid FAK phosphorylation in an agonist-dependent manner and on activation of protein kinase C [1,2]. FAK phosphorylation in response to co-stimulation with either fibrinogen or collagen and adenosine 5′-diphosphate (ADP) accompanies changes in platelet spreading [3]. However, as Fak deletion in mice is embryonic lethal at day 8.5, before the onset of significant hematopoiesis, the exact roles that FAK plays in platelet function in vivo remain elusive. To fully evaluate the role of FAK in platelet function, we successfully ablated Fak expression specifically in megakaryocytes and platelets by crossing conditional Fak-floxed mice [4] with megakaryocyte lineage–specific platelet factor 4 (Pf4)-Cre mice [5]. We found that Pf4-Cre/Fak-floxed (Fak−/−) mice exhibit increased bleeding times by tail bleed assays and attenuated platelet spreading. Recently, it was demonstrated an FAK inhibitor, PF-573,228, significantly attenuated platelet aggregation, spreading, and calcium release [6], suggesting that targeting FAK with specific pharmacological inhibitors may prevent thrombosis in high-risk patients. In this study, we further investigate the role of FAK in platelet function using platelet-specific Fak knockout mice and determine the effectiveness of FAK inhibitors, PF-573,228 (PF-228) and PF-573,271 (PF-271), in mediating platelet activity, in the presence and absence of FAK. We found that platelet aggregation was not significantly different in WT and Fak−/− mice in response to thrombin, ADP, or collagen (Fig. 1A). Platelet integrin expression was also not significantly different between the two groups (data not shown). Next, we determined the effects of FAK inhibitors PF-228 and PF-271 on platelet function in vitro. PF-228 and PF-271 both completely inhibited thrombin-mediated FAK phosphorylation in isolated WT platelets, while FAK was absent in Fak−/− platelets (data not shown). Despite the absence of FAK, however, PF-228 and PF-271 significantly inhibited platelet aggregation in response to thrombin, ADP, and collagen in Fak−/− platelets as well as WT (Fig. 1B). Fig. 1 Effects of Fak ablation and FAK inhibitors on platelet function and thrombosis. Animal procedures were performed in accordance to protocols approved by the Institutional Animal Care and Use Committee, Stony Brook University. (A) Platelet aggregation was ... Arterial occlusion times were measured using age-matched WT and Fak−/− mice (8–12 weeks) after injury with 7.5% FeCl3 to the carotid artery as described previously [7]. At 30 min before artery occlusion assays, mice received 50 mg/kg−1 PF-228 or PF-271 solubilized in cremephore DL/DMSO/ethanol (3:2:3) via intraperitoneal injection. Control mice received vehicle alone. Arterial occlusion time was not different between vehicle-treated WT and Fak−/− mice (WT, 545 ± 87 s; Fak−/−, 552 ± 71 s; Fig. 1C). Significantly, PF-271–treated WT and Fak−/− mice failed to occlude following injury throughout the 30-min test period. However, PF-228 had no effect on arterial thrombosis in vivo (Fig.1C). We have shown that the absence of FAK has no significant effects on arterial thrombosis following injury or platelet aggregation in response to ADP, collagen, or thrombin. One potential explanation for the apparent lack of platelet phenotype in Fak−/− mice is the compensatory role of the FAK homologue protein Pyk2. A number of reports describe increased expression and phosphorylation of Pyk2 when Fak is ablated and the increase in Pyk2 function is able to compensate for the absence of FAK [8,9]. Similarly, we observed that Pyk2 phosphorylation and expression are significantly increased in Fak−/− platelets (data not shown). Importantly, a recent publication determined the importance of Pyk2 in regulating integrin αIIbβ3 outside-in signaling in platelets, showing that Pyk2 ablation inhibited platelet adhesion and spreading on fibrinogen [10], further supporting the significance of Pyk2 in platelet function. Given the roles of FAK in cellular motility, adhesion, invasion, metastasis, and angiogenesis, the potential of FAK inhibitors as antioncogenic drugs has received considerable attention [11]. Both of the FAK inhibitors we have used in our studies, which directly affect the ATP binding site and thereby lower FAK kinase activity, have been shown to inhibit tumor growth in murine models [12,13]. However, the development of these drugs for clinical trials has been complicated by the structural similarities of the ATP-binding domain of many kinases, resulting in off-target effects of the inhibitors. We have shown that the FAK inhibitors have a significant effect on platelet aggregation in response to thrombin, collagen, and ADP, similar to the conclusions made previously [6]. However, we have shown that these effects are observed in both the presence and the absence of FAK. These data confirm that attenuation of platelet activity by treating with FAK inhibitors PF-228 and PF-271 is due to off-target effects rather than FAK inhibition. Considering PF-271 is now in phase I clinical trials, the significant inhibitory effects on platelet function should be considered as a potential side effect, although currently there are no reports of bleeding diatheses in treated patients.
- Published
- 2013
15. Anesthesia in the obese
- Author
-
V. Sanders, G. Andrieu, N. Chalons, F. Wierre, G. Lebuffe, B. Vallet, and K. Gorski
- Subjects
medicine.medical_treatment ,Treatment outcome ,MEDLINE ,Bariatric Surgery ,Anastomotic Leak ,Preoperative care ,Rhabdomyolysis ,Body Mass Index ,Peripheral Nerve Injuries ,Preoperative Care ,Intubation, Intratracheal ,Medicine ,Intubation ,Humans ,Surgical Wound Infection ,Anesthesia ,Obesity ,Anesthetics ,Postoperative Care ,business.industry ,Obesity Surgery ,General Medicine ,medicine.disease ,Obesity, Morbid ,Oxygen ,Treatment Outcome ,Cardiovascular Diseases ,business ,Body mass index - Published
- 2010
16. Planck pre-launch status:Design and description of the Low Frequency Instrument
- Author
-
M. Bersanelli, N. Mandolesi, R. C. Butler, A. Mennella, F. Villa, B. Aja, E. Artal, E. Artina, C. Baccigalupi, M. Balasini, G. Baldan, A. Banday, P. Bastia, P. Battaglia, T. Bernardino, E. Blackhurst, L. Boschini, C. Burigana, G. Cafagna, B. Cappellini, F. Cavaliere, F. Colombo, G. Crone, F. Cuttaia, O. D'Arcangelo, L. Danese, R. D. Davies, R. J. Davis, L. De Angelis, G. C. De Gasperis, L. De La Fuente, A. De Rosa, G. De Zotti, M. C. Falvella, F. Ferrari, R. Ferretti, L. Figini, S. Fogliani, C. Franceschet, E. Franceschi, T. Gaier, S. Garavaglia, F. Gomez, K. Gorski, A. Gregorio, P. Guzzi, J. M. Herreros, S. R. Hildebrandt, R. Hoyland, N. Hughes, M. Janssen, P. Jukkala, D. Kettle, V. H. Kilpiä, M. Laaninen, P. M. Lapolla, C. R. Lawrence, D. Lawson, J. P. Leahy, R. Leonardi, P. Leutenegger, S. Levin, P. B. Lilje, S. R. Lowe, P. M. Lubin, D. Maino, M. Malaspina, M. Maris, J. Marti-Canales, E. Martinez-Gonzalez, A. Mediavilla, P. Meinhold, M. Miccolis, G. Morgante, P. Natoli, R. Nesti, L. Pagan, C. Paine, B. Partridge, J. P. Pascual, F. Pasian, D. Pearson, M. Pecora, F. Perrotta, P. Platania, M. Pospieszalski, T. Poutanen, M. Prina, R. Rebolo, N. Roddis, J. A. Rubiño-Martin, M. J. Salmon, M. Sandri, M. Seiffert, R. Silvestri, A. Simonetto, P. Sjoman, G. F. Smoot, C. Sozzi, L. Stringhetti, E. Taddei, J. Tauber, L. Terenzi, M. Tomasi, J. Tuovinen, L. Valenziano, J. Varis, N. Vittorio, L. A. Wade, A. Wilkinson, F. Winder, A. Zacchei, A. Zonca, APC - Cosmologie, AstroParticule et Cosmologie (APC (UMR_7164)), Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), PLANCK, Universidad de Cantabria, Bersanelli, M, Mandolesi, N, BUTLER R., C, Mennella, A, Villa, F, Aja, B, Artal, E, Artina, E, Baccigalupi, C, Balasini, M, Baldan, G, Banday, A, Bastia, P, Battaglia, P, Bernardino, T, Blackhurst, E, Boschini, L, Burigana, C, Cafagna, G, Cappellini, B, Cavaliere, F, Colombo, F, Crone, G, Cuttaia, F, Darcangelo, O, Danese, L, DAVIES R., D, DAVIS R., J, DE ANGELIS, L, DE GASPERIS G., C, DE LA FUENTE, L, DE ROSA, A, DE ZOTTI, G, FALVELLA M., C, Ferrari, F, Ferretti, R, Figini, L, Fogliani, S, Franceschet, C, Franceschi, E, Gaier, T, Garavaglia, S, Gomez, F, Gorski, K, Gregorio, Anna, Guzzi, P, HERREROS J., M, HILDEBRANDT S., R, Hoyland, R, Hughes, N, Janssen, M, Jukkala, P, Kettle, D, KILPIA V., H, Laaninen, M, LAPOLLA P., M, LAWRENCE C., R, Lawson, D, LEAHY J., P, Leonardi, R, Leutenegger, P, Levin, S, LILJE P., B, LOWE S., R, LUBIN P., M, Maino, D, Malaspina, M, Maris, M, MARTI CANALES, J, MARTINEZ GONZALEZ, E, Mediavilla, A, Meinhold, P, Miccolis, M, Morgante, G, Natoli, P, Nesti, R, Pagan, L, Paine, C, Partridge, B, PASCUAL J., P, Pasian, F, Pearson, D, Pecora, M, Perrotta, F, Platania, P, Pospieszalski, M, Poutanen, T, Prina, M, Rebolo, R, Roddis, N, RUBINO MARTIN J., A, SALMON M., J, Sandri, M, Seiffert, M, Silvestri, R, Simonetto, A, Sjoman, P, SMOOT G., F, Sozzi, C, Stringhetti, L, Taddei, E, Tauber, J, Terenzi, L, Tomasi, M, Tuovinen, J, Valenziano, L, Varis, J, Vittorio, N, WADE L., A, Wilkinson, A, Winder, F, Zacchei, A, Zonca, A., Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Physique Corpusculaire et Cosmologie - Collège de France (PCC), Collège de France (CdF)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Collège de France (CdF)-Centre National de la Recherche Scientifique (CNRS), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, and Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
detectors – instrumentation ,Computer science ,[SDU.ASTR.CO]Sciences of the Universe [physics]/Astrophysics [astro-ph]/Cosmology and Extra-Galactic Astrophysics [astro-ph.CO] ,Cosmic microwave background ,cosmic microwave background ,cosmology: observations ,space vehicles: instruments ,01 natural sciences ,7. Clean energy ,CMB physics ,observations [Cosmology] ,010303 astronomy & astrophysics ,Planck ESA mission ,Astrophysics::Instrumentation and Methods for Astrophysics ,Polarization (waves) ,symbols ,Radiometric dating ,Astrophysics - Instrumentation and Methods for Astrophysics ,Astrophysics - Cosmology and Nongalactic Astrophysics ,Cosmology and Nongalactic Astrophysics (astro-ph.CO) ,FOS: Physical sciences ,Low frequency ,Radio spectrum ,instruments – instrumentation [cosmic microwave background – telescopes – space vehicles] ,[PHYS.ASTR.CO]Physics [physics]/Astrophysics [astro-ph]/Cosmology and Extra-Galactic Astrophysics [astro-ph.CO] ,instruments [Space vehicles] ,symbols.namesake ,Settore FIS/05 - Astronomia e Astrofisica ,0103 physical sciences ,Electronic engineering ,Calibration ,Black-body radiation ,Sensitivity (control systems) ,Planck ,Instrumentation and Methods for Astrophysics (astro-ph.IM) ,cosmic microwave background – telescopes – space vehicles: instruments – instrumentation ,Radiometer ,cosmology-observations ,010308 nuclear & particles physics ,Amplifier ,Astronomy and Astrophysics ,polarimeters – submillimeter ,Space and Planetary Science ,general ,space vehicles-instruments ,Microwave - Abstract
21 páginas, 23 figuras, 13 tablas.-- et al., In this paper we present the Low Frequency Instrument (LFI), designed and developed as part of the Planck space mission, the ESA programme dedicated to precision imaging of the cosmic microwave background (CMB). Planck-LFI will observe the full sky in intensity and polarisation in three frequency bands centred at 30, 44 and 70 GHz, while higher frequencies (100–850 GHz) will be covered by the HFI instrument. The LFI is an array of microwave radiometers based on state-of-the-art indium phosphide cryogenic HEMT amplifiers implemented in a differential system using blackbody loads as reference signals. The front end is cooled to 20 K for optimal sensitivity and the reference loads are cooled to 4 K to minimise low-frequency noise. We provide an overview of the LFI, discuss the leading scientific requirements, and describe the design solutions adopted for the various hardware subsystems. The main drivers of the radiometric, optical, and thermal design are discussed, including the stringent requirements on sensitivity, stability, and rejection of systematic effects. Further details on the key instrument units and the results of ground calibration are provided in a set of companion papers., T.P.’s work was supported in part by the Academy of Finland grants 205800, 214598, 121703, and 121962. T.P. thanks the Waldemar von Frenckells Stiftelse, Magnus Ehrnrooth Foundation, and Väisälä Foundation for financial support. We acknowledge partial support from the NASA LTSA Grant NNG04CG90G.
- Published
- 2010
- Full Text
- View/download PDF
17. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha
- Author
-
Olga T. Hardy, Christian J. Stoeckert, Rana K. Gupta, Kiran Rafiq, John Brestelli, Nan Gao, Klaus H. Kaestner, Guang Chen, Regina K. Gorski, and Peter White
- Subjects
Transcription, Genetic ,Transgene ,Molecular Sequence Data ,Regulator ,Mice, Transgenic ,digestive system ,Islets of Langerhans ,Mice ,Pregnancy ,Insulin-Secreting Cells ,Genetics ,Animals ,Extracellular Signal-Regulated MAP Kinases ,Cell Proliferation ,biology ,Base Sequence ,Models, Genetic ,Cell growth ,Tumor Suppressor Proteins ,Phenotype ,Molecular biology ,Cell biology ,DNA-Binding Proteins ,Hepatocyte nuclear factor 4 ,Nuclear receptor ,Hepatocyte Nuclear Factor 4 ,Mitogen-activated protein kinase ,embryonic structures ,biology.protein ,ras Proteins ,Female ,Signal transduction ,Developmental Biology ,Signal Transduction ,Research Paper - Abstract
The failure to expand functional pancreatic β-cell mass in response to increased metabolic demand is a hallmark of type 2 diabetes. Lineage tracing studies indicate that replication of existing β-cells is the principle mechanism for β-cell expansion in adult mice. Here we demonstrate that the proliferative response of β-cells is dependent on the orphan nuclear receptor hepatocyte nuclear factor-4α (HNF-4α), the gene that is mutated in Maturity-Onset Diabetes of the Young 1 (MODY1). Computational analysis of microarray expression profiles from isolated islets of mice lacking HNF-4α in pancreatic β-cells reveals that HNF-4α regulates selected genes in the β-cell, many of which are involved in proliferation. Using a physiological model of β-cell expansion, we show that HNF-4α is required for β-cell replication and the activation of the Ras/ERK signaling cascade in islets. This phenotype correlates with the down-regulation of suppression of tumorigenicity 5 (ST5) in HNF-4α mutants, which we identify as a novel regulator of ERK phosphorylation in β-cells and a direct transcriptional target of HNF-4α in vivo. Together, these results indicate that HNF-4α is essential for the physiological expansion of adult β-cell mass in response to increased metabolic demand.
- Published
- 2007
18. Novel genes identified by manual annotation and microarray expression analysis in the pancreas
- Author
-
Alexey Katokhin, Alexandre Shilov, Marina Gubina, Athanasios Arsenlis, Nadezhda Vorobjeva, Nikolay A. Kolchanov, Peter White, Eugenij Elisafenko, Olga Belova, Polina Perelman, Vladimir Trifonoff, Vera Bogdanova, Deborah F. Pinney, Klaus H. Kaestner, John Brestelli, Christian J. Stoeckert, Lilia Nizolenko, Mikhail Puzakov, Joan M. Mazzarelli, and Regina K. Gorski
- Subjects
Signal peptide ,DNA, Complementary ,Microarray ,Transcription, Genetic ,Annotation ,MicroRNA Gene ,Biology ,Clones ,03 medical and health sciences ,Islets of Langerhans ,Mice ,0302 clinical medicine ,Mice, Inbred NOD ,Complementary DNA ,Gene expression ,Genetics ,Animals ,Cloning, Molecular ,Gene ,Pancreas ,030304 developmental biology ,0303 health sciences ,Genome ,Microarray analysis techniques ,Gene Expression Profiling ,Islet cells ,Computational Biology ,Proteins ,Transcript ,Microarray Analysis ,Gene expression profiling ,Diabetes Mellitus, Type 1 ,030217 neurology & neurosurgery ,cDNA array - Abstract
The mouse PancChip, a microarray developed for studying endocrine pancreatic development and diabetes, represents over 13,000 cDNAs. After computationally assigning the cDNAs on the array to known genes, manual curation of the remaining sequences identified 211 novel transcripts. In microarray experiments, we found that 196 of these transcripts were expressed in total pancreas and/or pancreatic islets. Of 50 randomly selected clones from these 196 transcripts, 92% were confirmed as expressed by qRT-PCR. We evaluated the coding potential of the novel transcripts and found that 74% of the clones had low coding potential. Since the transcripts may be partial mRNAs, we examined their translated proteins for transmembrane or signal peptide domains and found that about 40 proteins had one of these predicted domains. Interestingly, when we investigated the novel transcripts for their overlap with noncoding microRNAs, we found that 1 of the novel transcripts overlapped a known microRNA gene.
- Published
- 2006
19. ROM-based finite state machines with PLA address modifiers
- Author
-
T. Luba, K. Gorski, and L.B. Wronski
- Published
- 2003
- Full Text
- View/download PDF
20. A complementary disk-shaped π electron donor–acceptor pair with high binding affinity
- Author
-
David Hanifi, Ewa K. Gorski, Yi Liu, Qin Wu, Gayane Koshkakaryan, Minghui Chai, Liana M. Klivansky, and Daniel R. Holycross
- Subjects
chemistry.chemical_classification ,Stereochemistry ,Triphenylene ,Charge density ,Electron donor ,General Chemistry ,Electron ,Electron acceptor ,Electrostatics ,Acceptor ,chemistry.chemical_compound ,Crystallography ,chemistry ,Thin film - Abstract
Hexaazatriphenylene triimides (HAT) have been shown to be a novel class of disk-shaped π electron acceptors that pair with donors with complementary shape and electron demands, such as triphenylene (TP) derivatives. The donor–acceptor (DA) pair forms a strong charge-transfer complex in CH2Cl2 with an association constant of 2.6 × 104 M−1, which is remarkable for a recognition system that is solely based on electrostatic interactions between two π systems. NMR studies, along with molecular modelling, have revealed a complementary charge distribution and an “eclipsed” conformation in the DA complex. The strong DA interaction results in extended alternating DA stacks in the thin film and mesophases.
- Published
- 2012
- Full Text
- View/download PDF
21. Consequences of delays for women seeking state-subsidized insurance for abortion care in the commonwealth of Massachusetts
- Author
-
D. Jinadasa, M.J. Peterson, Danielle Bessett, M. Ostrow, and K. Gorski
- Subjects
Economic growth ,Reproductive Medicine ,State (polity) ,media_common.quotation_subject ,Economics ,Obstetrics and Gynecology ,Commonwealth ,Subsidy ,Abortion ,media_common - Published
- 2011
- Full Text
- View/download PDF
22. Alterations at the rel locus in human lymphoma
- Author
-
D, Lu, J D, Thompson, G K, Gorski, N R, Rice, M G, Mayer, and J J, Yunis
- Subjects
Chromosome Aberrations ,Gene Rearrangement ,Base Sequence ,Molecular Sequence Data ,Gene Amplification ,Nucleic Acid Hybridization ,DNA Restriction Enzymes ,Transfection ,Proto-Oncogene Mas ,Proto-Oncogene Proteins c-rel ,Chromosomes, Human, Pair 2 ,Proto-Oncogene Proteins ,Proto-Oncogenes ,Tumor Cells, Cultured ,Humans ,Amino Acid Sequence ,Lymphoma, Large B-Cell, Diffuse ,Cloning, Molecular ,DNA Probes - Abstract
The rel proto-oncogene has been mapped to chromosome region 2p11.2-14, a site associated with nonrandom rearrangements in non-Hodgkin's lymphoma. We have characterized an abnormal rel mRNA from a cell line derived from a diffuse large cell lymphoma, in which the evolutionarily conserved N-terminal half of the rel coding region was fused with the C-terminal coding region of an unrelated gene. In addition, rearrangement or amplification of the rel locus was found in the lymphomatous tissue of two follicular and one diffuse large cell lymphoma. The findings suggest involvement of rel in the pathogenesis of large cell lymphoma.
- Published
- 1991
23. Improved inversion attacks on nonlinear filter generators
- Author
-
K. Gorski and A. Gorska
- Subjects
Adaptive filter ,Filter design ,Computational complexity theory ,Control theory ,Nonlinear filter ,Kernel adaptive filter ,Electrical and Electronic Engineering ,Topology ,Raised-cosine filter ,Computer Science::Cryptography and Security ,Shift register ,Mathematics ,Root-raised-cosine filter - Abstract
Improved inversion attacks on nonlinear filter generators are proposed with computational complexity equal to O(2/sup r-m/), where r denotes the length of the shift register, and m denotes the largest gap between cells with taps to the filter function or connection polynomial. It is shown that the previously proposed set of design criteria does not prevent the improved inversion attack and an additional criterion is proposed based on the relationship between the positions of taps to the filter function and positions of taps to the connection polynomial.
- Published
- 2002
- Full Text
- View/download PDF
24. THE POTENTIAL OF LIGHT LASER SCANNERS DEVELOPED FOR UNMANNED AERIAL VEHICLES – THE REVIEW AND ACCURACY
- Author
-
M. Pilarska, W. Ostrowski, K. Bakuła, K. Górski, and Z. Kurczyński
- Subjects
Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Applied optics. Photonics ,TA1501-1820 - Abstract
Modern photogrammetry and remote sensing have found small Unmanned Aerial Vehicles (UAVs) to be a valuable source of data in various branches of science and industry (e.g., agriculture, cultural heritage). Recently, the growing role of laser scanning in the application of UAVs has also been observed. Laser scanners dedicated to UAVs consist of four basic components: a laser scanner (LiDAR), an Inertial Measurement Unit (IMU), a Global Navigation Satellite System (GNSS) receiver and an on-board computer. The producers of the system provide users with detailed descriptions of the accuracies separately for each component. However, the final measurement accuracy is not given. This paper reviews state-of-the-art of laser scanners developed specifically for use on a UAV, presenting an overview of several constructions that are available nowadays. The second part of the paper is focussed on analysing the influence of the sensor accuracies on the final measurement accuracy. Mathematical models developed for Airborne Laser Scanning (ALS) accuracy analyses are used to estimate the theoretical accuracies of different scanners with conditions typical for UAV missions. Finally, the theoretical results derived from the mathematical simulations are compared with an experimental use case.
- Published
- 2016
- Full Text
- View/download PDF
25. POSSIBILITIES FOR USING LIDAR AND PHOTOGRAMMETRIC DATA OBTAINED WITH AN UNMANNED AERIAL VEHICLE FOR LEVEE MONITORING
- Author
-
K. Bakuła, W. Ostrowski, M. Szender, W. Plutecki, A. Salach, and K. Górski
- Subjects
Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Applied optics. Photonics ,TA1501-1820 - Abstract
This paper presents the possibilities for using an unmanned aerial system for evaluation of the condition of levees. The unmanned aerial system is equipped with two types of sensor. One is an ultra-light laser scanner, integrated with a GNSS receiver and an INS system; the other sensor is a digital camera that acquires data with stereoscopic coverage. Sensors have been mounted on the multirotor, unmanned platform the Hawk Moth, constructed by MSP company. LiDAR data and images of levees the length of several hundred metres were acquired during testing of the platform. Flights were performed in several variants. Control points measured with the use of the GNSS technique were considered as reference data. The obtained results are presented in this paper; the methodology of processing the acquired LiDAR data, which increase in accuracy when low accuracy of the navigation systems occurs as a result of systematic errors, is also discussed. The Iterative Closest Point (ICP) algorithm, as well as measurements of control points, were used to georeference the LiDAR data. Final accuracy in the order of centimetres was obtained for generation of the digital terrain model. The final products of the proposed UAV data processing are digital elevation models, an orthophotomap and colour point clouds. The authors conclude that such a platform offers wide possibilities for low-budget flights to deliver the data, which may compete with typical direct surveying measurements performed during monitoring of such objects. However, the biggest advantage is the density and continuity of data, which allows for detection of changes in objects being monitored.
- Published
- 2016
- Full Text
- View/download PDF
26. EFFORT OF STEEL PIPE JACKING IN TERMS OF IMPERFECTION PIPES AND HETEROGENEITY OF GROUND
- Author
-
K. Górski and R. L. Ignatowicz
- Subjects
steel pipe ,finite element method ,microtunneling ,ground ,Transportation engineering ,TA1001-1280 - Abstract
Purpose. The article presents problem of the influence of local inhomogeneities of ground on the internal forces in the steel pipe. Methodology. The authors presented the differences in the distributions of earth pressures for the pipes. One of the most common methods is the microtunneling technology. The examples of numerical analysis by finite element method (FEM) have been calculated. Findings. The results of numerical analysis are presented for selected ground conditions and the distribution of internal forces in the flexible section of the steel pipe is also shown. Originality and Practical value. The obtained results clearly show the influence of flexural rigidity of the pipe on the internal forces, the influence of flexural rigidity and the soil stiffness on the size of the bending moments in the steel of pipe jacking. They depend on the interaction of soil – steel pipe.
- Published
- 2016
- Full Text
- View/download PDF
27. Tissue-specific in vitro transcription from the mouse albumin promoter
- Author
-
K. Gorski, Carneiro M, and U. Schibler
- Subjects
Genes, Viral ,Transcription, Genetic ,Recombinant Fusion Proteins ,Response element ,Spleen ,RNA polymerase II ,General Biochemistry, Genetics and Molecular Biology ,Adenoviridae ,Mice ,Transcription (biology) ,ddc:570 ,Albumins ,medicine ,Animals ,Humans ,Promoter Regions, Genetic ,Gene ,Cell Nucleus ,Base Sequence ,biology ,Albumin ,Brain ,Promoter ,Molecular biology ,Rats ,medicine.anatomical_structure ,Liver ,Organ Specificity ,biology.protein ,RNA Polymerase II ,Transcription factor II D ,HeLa Cells - Abstract
Transcriptionally active nuclear extracts have been prepared from rat liver, brain, and spleen. The adenovirus-2 major late promoter directs efficient transcription by RNA polymerase II in all of these extracts, whereas the promoter of the mouse albumin gene is significantly used only in the liver extract. Albumin sequences located between -170 and -55 are required for this liver-specific in vitro transcription, since deletion of this region results in almost a 100-fold reduction in transcription. In addition, insertion of these sequences in either orientation upstream of the parotid-specific Amy-1 promoter, which is poorly transcribed in the liver extract, increases the activity of this promoter to a level comparable to that observed for the albumin promoter.
- Published
- 1986
- Full Text
- View/download PDF
28. The use of sexual activity measurements to assess ejaculatory performance of boars
- Author
-
S. Kondracki, M. Iwanina, A. Wysokińska, and K. Górski
- Subjects
Agriculture ,Animal culture ,SF1-1100 ,Science ,Zoology ,QL1-991 - Abstract
The study involved 50 insemination boars at the age of 8–9 months at the beginning of the study. Each boar was assessed four times for its sexual activity: at the beginning of breeding service and after three, six and nine months into the insemination service. Ejaculates were collected for the purpose of the sexual activity parameters’ assessment. Physical parameters of the ejaculates were subsequently analysed. Pearson’s linear correlation was used to calculate the coefficients of a phenotypic correlation between sexual activity levels and physical parameters of the ejaculates. According to this an appropriate analysis was conducted concerning the changes in boars’ sexual activity throughout their dynamic, sexual development. It was proved, that ejaculate volume depends on the total time of copulation. The highest correlation between ejaculate volume and sexual urge levels was observed in the youngest boars at the beginning of insemination service. The correlation between the ejaculatory efficiency and a boar’s libido changes with age and sexual development. Changes in ejaculatory efficiency are the most dynamic at the age of approx. 1.5 years. At this age ejaculate volume and ejaculate sperm count dynamically increase. The insemination fitness forecasting in case of boars should include libido measurements taken at the beginning of an insemination service – within the first three months. Measurements taken at a more advanced age are of little use for the purpose of ejaculatory efficiency forecasting in case of boars.
- Published
- 2013
- Full Text
- View/download PDF
29. Another possible case of a gravitational lens
- Author
-
K. Gorski and Bohdan Paczynski
- Subjects
Physics ,Velocity dispersion ,Astronomy ,Astronomy and Astrophysics ,Quasar ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,Redshift ,Galaxy ,Radial velocity ,Gravitational lens ,Galaxy groups and clusters ,Space and Planetary Science ,Galaxy cluster - Abstract
A cluster of three quasars at redshift 2.05 discovered by Burbidge et al. may be a triple image of a single quasar produced by two spherical clusters of galaxies acting as a gravitational lens. The core radii and velocity dispersions required for the clusters by our model are not unreasonable, but a positive cosmological constant would bring the velocity dispersion within clusters down, closer to that commonly observed. If the clusters were discovered and their redshifts and velocity dispersions were measured, then an estimate of the cosmological constant could be made.
- Published
- 1981
- Full Text
- View/download PDF
30. Progressive worsening of posttraumatic stress symptoms in Syrian and Iraqi refugees associated with cumulative and victimization trauma: A longitudinal study.
- Author
-
Hinchey LM, Alahmad R, Gorski K, and Javanbakht A
- Abstract
Background: War and forced migration expose refugees to trauma and ongoing stress, often contributing to long-term psychological consequences. Typically, trauma exposure is assessed cumulatively; yet, trauma type may better predict psychological outcomes. This study examined the differential impact of cumulative trauma and trauma subtypes (victimization, death threat, accidental/injury) on postmigration trajectories of posttraumatic stress and anxiety in refugees., Method: Seventy-seven Syrian (88.3%) and Iraqi (9.1%) adult refugees self-reported prior trauma exposure and psychological symptoms at time of arrival in the United States and 2 years post. Linear mixed-effects modeling was performed to assess for associations between trauma variables and symptom trajectories. Models using cumulative trauma as a predictor were compared to models including the three trauma subtype variables as predictors, using pseudo- R ² values to compare variance explained between the two methods of trauma measurement., Results: Linear mixed-effects modeling indicated that prior exposure to victimization predicted progressively worsening posttraumatic stress disorder (PTSD) symptoms over time postmigration ( b = .97, SE = .45, t = 2.14, p = .036). Cumulative trauma also predicted increasing PTSD symptoms ( b = .124, SE = .06, t = 2.09, p = .041), but explained less variance than victimization (9% vs. 18.1%). Direct effects of cumulative trauma ( p = .009) and victimization ( p = .002) on anxiety severity emerged; however, anxiety symptoms did not change over time depending on prior trauma exposure. Accidents/injuries and death threats did not predict PTSD or anxiety., Conclusions: These findings can be leveraged toward focused identification of those at highest risk for progressive illness postmigration, thus providing empirical guidance for allocation of interventions and resources for refugees. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Published
- 2024
- Full Text
- View/download PDF
31. Unreal that feels real: artificial intelligence-enhanced augmented reality for treating social and occupational dysfunction in post-traumatic stress disorder and anxiety disorders.
- Author
-
Javanbakht A, Hinchey L, Gorski K, Ballard A, Ritchie L, and Amirsadri A
- Subjects
- Humans, Implosive Therapy, Stress Disorders, Post-Traumatic therapy, Artificial Intelligence, Augmented Reality, Anxiety Disorders therapy
- Abstract
Background: Fear- and trauma-related conditions, such as post-traumatic stress disorder (PTSD) and social phobia, often manifest as socially avoidant behaviours, which commonly contribute to social and occupational disability transdiagnostically. While gold-standard treatments (i.e. exposure therapy, psychotropic medications) are effective, they are hindered by high dropout rates and limited impact on real-world functioning. Furthermore, most existing interventions only target symptom reduction, with few addressing avoidance-related deficits in social and occupational functioning. Objectives: This methods paper introduces an innovative augmented reality exposure therapy (ARET) technology designed to address the limitations of traditional interventions for anxiety disorders and PTSD, by directly targeting social and occupational dysfunction through exposure to real-life social contexts. Method: We introduce an ARET system, using artificial intelligence (AI)-driven, augmented reality (AR) technology, that enables exposure to realistic scenarios within the patient's real-world environment, fostering contextual generalization and functional improvement. Featuring holographic three-dimensional humans, precise surface mapping, wireless mobility, and telemedicine capabilities, the software provides customizable exposure scenarios to transform an environment into various spaces (e.g. grocery store, house party) with diverse human characters, as well as flexible AI-driven human interactions tailored to individual needs. Results: We share observations and feedback from the treatment of first responders with PTSD. Patients found the technology easy to use, with immersive realism, active engagement, and strong emotional responses needed for effective exposure therapy. Advances in AI-driven character development and AR hardware accessibility support the wider adoption of ARET by clinicians. Conclusion: By bridging the gap between clinical interventions and real-world functioning, ARET offers a transformative approach to addressing the pervasive impact of psychiatric disorders on social and occupational outcomes.
- Published
- 2024
- Full Text
- View/download PDF
32. What happened matters: Trauma type and cumulative trauma exposure in refugee youth psychopathology.
- Author
-
Hinchey LME, Chammaa M, Ruvolo Grasser L, Saad B, Gorski K, and Javanbakht A
- Abstract
Objective: Trauma exposure-a contributor to psychological risk for refugee youth-is typically assessed using cumulative indices; however, recent findings indicate that trauma type may better predict psychological outcomes. This study investigated the utility of two methods of classifying trauma exposure-cumulative trauma and exposure to specific types of trauma (i.e., trauma subtypes)-in predicting the severity of symptoms related to posttraumatic stress disorder (PTSD) and anxiety for refugee youth., Method: 96 Syrian and Iraqi youth resettled as refugees in the United States self-reported trauma exposure and psychological symptoms. Multiple regression was used to assess the variance in symptom severity explained by specific trauma subtypes (i.e., victimization, death threat, and accidental/injury) as compared to cumulative trauma scores., Results: Multiple regression models predicting PTSD revealed cumulative trauma ( b = 0.07; p = .004) and death threat trauma ( b = 0.16; p = .001) as significant predictors of PTSD symptom severity; notably, death threat trauma was the only subtype associated with PTSD and explained more variance than cumulative trauma scores (10.3% and 8.4%, respectively). Cumulative trauma, but no specific trauma subtype, was associated with anxiety ( b = .03; p = .043); however, this relation did not survive correction for multiple comparisons., Conclusion: Focused trauma assessment-particularly consideration of death threat trauma and cumulative trauma exposures-may be useful in evaluating the risk of PTSD symptoms in refugee youth, whereas symptoms related to anxiety may be driven by other factors. These findings can be leveraged toward focused identification of youth at highest risk for PTSD symptoms, to improve prevention and early intervention efforts. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
- Published
- 2023
- Full Text
- View/download PDF
33. The longitudinal impact of war exposure on psychopathology in Syrian and Iraqi refugee youth.
- Author
-
Hinchey LM, Nashef R, Bazzi C, Gorski K, and Javanbakht A
- Subjects
- Child, Humans, Adolescent, Syria, Iraq epidemiology, War Exposure adverse effects, Refugees psychology, Stress Disorders, Post-Traumatic epidemiology, Stress Disorders, Post-Traumatic etiology
- Abstract
Background: War and natural disasters lead to forced migration - and increased risk of adverse psychological outcomes - in approximately 1% of the global population. Though recent years have brought a greater understanding of the consequences of war exposure on mental health outcomes for refugee children, little is known about the longitudinal and developmental impact of these experiences on youth., Aims: The aim of this study was to assess the effect of direct exposure to war and/or combat on trajectories of symptoms related to anxiety and post-traumatic stress disorder (PTSD) in Syrian and Iraqi refugee youth following resettlement. Prevalence of possible anxiety disorders and PTSD was also assessed., Method: Participants included accompanied refugee youth resettled in the state of Michigan in the U.S. ( n = 74). Youth filled out self-report measures of trauma exposure, anxiety symptoms, and PTSD symptoms upon arrival and 2 years later. Linear mixed-effects modeling was used to assess the effect of war exposure over time., Results: Upon arrival, 38% screened positive for an anxiety disorder and 4.1% met diagnostic thresholds for PTSD. While war exposure did not predict changes to PTSD symptom trajectories ( p = .481), anxiety symptoms increased over time among children reporting war exposure ( B = 10.13, SE = 4.22, t = 2.40, p = .019)., Conclusions: Our findings suggest that without appropriate interventions, anxiety- and trauma-related symptoms often do not decrease. Further, exposure to war trauma may lead to progressive worsening of symptoms. These findings suggest that assessing for type of trauma exposure, rather than focusing solely on migration status, may inform focused attention and interventions among trauma-exposed children resettling as refugees., Competing Interests: Conflict of interestThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2023
- Full Text
- View/download PDF
34. Progressive mitochondrial dysfunction in cerebellar synaptosomes of cystatin B-deficient mice.
- Author
-
Gorski K, Jackson CB, Nyman TA, Rezov V, Battersby BJ, and Lehesjoki AE
- Abstract
The involvement of mitochondrial dysfunction in cystatin B (CSTB) deficiency has been suggested, but its role in the onset of neurodegeneration, myoclonus, and ataxia in the CSTB-deficient mouse model ( Cstb
-/- ) is yet unknown. CSTB is an inhibitor of lysosomal and nuclear cysteine cathepsins. In humans, partial loss-of-function mutations cause the progressive myoclonus epilepsy neurodegenerative disorder, EPM1. Here we applied proteome analysis and respirometry on cerebellar synaptosomes from early symptomatic ( Cstb-/- ) mice to identify the molecular mechanisms involved in the onset of CSTB-deficiency associated neural pathogenesis. Proteome analysis showed that CSTB deficiency is associated with differential expression of mitochondrial and synaptic proteins, and respirometry revealed a progressive impairment in mitochondrial function coinciding with the onset of myoclonus and neurodegeneration in ( Cstb-/- ) mice. This mitochondrial dysfunction was not associated with alterations in mitochondrial DNA copy number or membrane ultrastructure. Collectively, our results show that CSTB deficiency generates a defect in synaptic mitochondrial bioenergetics that coincides with the onset and progression of the clinical phenotypes, and thus is likely a contributor to the pathogenesis of EPM1., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Gorski, Jackson, Nyman, Rezov, Battersby and Lehesjoki.)- Published
- 2023
- Full Text
- View/download PDF
35. The Predictive Utility of Trauma Subtypes in the Assessment of Mental Health Outcomes for Persons Resettled as Refugees.
- Author
-
Hinchey LM, Grasser LR, Saad B, Gorski K, Pernice F, and Javanbakht A
- Subjects
- Humans, Depression, Anxiety, Outcome Assessment, Health Care, Refugees psychology, Stress Disorders, Post-Traumatic diagnosis, Stress Disorders, Post-Traumatic psychology
- Abstract
Pre-migration trauma, a psychological risk factor for refugees, is often measured using cumulative indices. However, recent research suggests that trauma subtypes, rather than cumulative trauma, may better predict psychological outcomes. This study investigated the predictive utility of trauma subtypes in the assessment of refugee mental health. Multiple regression was used to determine whether cumulative trauma or trauma subtypes explained more variance in depression, anxiety, and post-traumatic stress disorder (PTSD) symptom scores in 70 Syrian and Iraqi refugees. Subtype models performed better than cumulative trauma models for PTSD (cumulative R
2 = 0.138; subtype R2 = 0.32), anxiety (cumulative R2 = 0.061; subtype R2 = 0.246), and depression (cumulative R2 = 0.041; subtype R2 = 0.184). Victimization was the only subtype significantly associated with PTSD (p < 0.001; r2 = 0.210), anxiety (p < 0.001; r2 = 0.162), and depression (p = 0.002; r2 = 0.140). Cumulative trauma was predictive of PTSD symptoms only (p = 0.003; r2 = 0.125). Trauma subtypes were more informative than cumulative trauma, indicating their utility for improving predictive efforts in research and clinical contexts., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
36. Vulvar sebaceous hyperplasia - a problematic dermatosis of the vulva.
- Author
-
Gorski K, Korczynska L, Spiewankiewicz B, Swiderska K, Baczkowska M, Skowyra A, and Ciebiera M
- Subjects
- Female, Humans, Male, Adult, Hyperplasia, Skin, Pruritus, Vulva, Skin Diseases
- Abstract
Sebaceous glandular hyperplasia (SGH) is a benign form of skin pathology, occurring in approximately one percent of the population. Risk factors for the SGH include advanced age, male sex, exposure to UV radiation and immunosuppression. The pathogenesis of SGH involves hormonal changes, is also regulated by insulin levels, thyroid stimulating hormone (TSH) and cortisol. SGH manifests itself as solitary or multiple light-yellow lumps, 2-3 mm big, with a smooth surface and a central umbilical depression. The vulvar localization of lesions is extremely rare and presents with a polymorphous clinical picture, posing a major diagnostic problem. A 40-year-old patient presented to the clinic due to vulvar skin lesions, periodically with the swelling of the labia and itching, with the symptoms deteriorating for approximately two years. The patient has been consulted by several doctors; however, the diagnosis has not been established. She did not receive adequate treatment either. On physical examination, attention was drawn to the overgrown labia minora - especially on the right side - with a network of abnormal vessels and numerous small papular lesions. SGH was diagnosed, based on the samples collected from the vulva. The patient was recommended isotretinoin therapy and referred to a dermatologist for a consultation. The presented case of vulvar SGH is interesting and rare. It is a diagnostic challenge with no established treatment standards. Nonetheless, SGH should be considered in the differential diagnosis of vulvar skin lesions. The comprehensive and interdisciplinary care is needed to help patients struggling with this insidious condition.
- Published
- 2023
- Full Text
- View/download PDF
37. Research With Refugees and Vulnerable Populations in a Post-COVID World: Challenges and Opportunities.
- Author
-
Saad B, George SA, Bazzi C, Gorski K, Abou-Rass N, Shoukfeh R, and Javanbakht A
- Subjects
- Child, Humans, Pandemics, Vulnerable Populations, Prospective Studies, Refugees, COVID-19
- Abstract
At the Stress, Trauma and Anxiety Research Clinic (STARC) at Wayne State University in Detroit, we are currently amid data collection for a longitudinal prospective study of Syrian refugee children and their parents. Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, our goal is to understand the impact of exposure to war trauma and the stress of migration on symptoms of posttraumatic stress disorder, anxiety, and depression, as well as the neurobiological, epigenetic, and environmental correlates of risk and resilience. Like many research groups around the world, the COVID-19 pandemic brought our work to a screeching halt. Researchers who, like us, were engaged in human subjects research were left grappling with the question of how to continue their work while ensuring the safety of both research staff and participants, and while maintaining scientific integrity. In March 2020, our institution halted all in-person human subjects research that did not have direct benefits to participants, which continued until October, when research activity was resumed subject to implementation of modified procedures. Over the past 2 years, we have pivoted, adapted, and flexed, ultimately making changes that have allowed us to continue successful data collection throughout the pandemic. This article will discuss the specific challenges of working with ethnically minoritized and immigrant populations during the pandemic, the adaptations that we implemented to enable safe and effective data collection, as well as the new knowledge that we can apply to future research protocols., (Copyright © 2022 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Quantitative Changes in the Mitochondrial Proteome of Cerebellar Synaptosomes From Preclinical Cystatin B-Deficient Mice.
- Author
-
Gorski K, Spoljaric A, Nyman TA, Kaila K, Battersby BJ, and Lehesjoki AE
- Abstract
Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1) is a neurodegenerative disorder caused by loss-of-function mutations in the cystatin B ( CSTB ) gene. Progression of the clinical symptoms in EPM1 patients, including stimulus-sensitive myoclonus, tonic-clonic seizures, and ataxia, are well described. However, the cellular dysfunction during the presymptomatic phase that precedes the disease onset is not understood. CSTB deficiency leads to alterations in GABAergic signaling, and causes early neuroinflammation followed by progressive neurodegeneration in brains of a mouse model, manifesting as progressive myoclonus and ataxia. Here, we report the first proteome atlas from cerebellar synaptosomes of presymptomatic Cstb -deficient mice, and propose that early mitochondrial dysfunction is important to the pathogenesis of altered synaptic function in EPM1. A decreased sodium- and chloride dependent GABA transporter 1 (GAT-1) abundance was noted in synaptosomes with CSTB deficiency, but no functional difference was seen between the two genotypes in electrophysiological experiments with pharmacological block of GAT-1. Collectively, our findings provide novel insights into the early onset and pathogenesis of CSTB deficiency, and reveal greater complexity to the molecular pathogenesis of EPM1., (Copyright © 2020 Gorski, Spoljaric, Nyman, Kaila, Battersby and Lehesjoki.)
- Published
- 2020
- Full Text
- View/download PDF
39. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
- Author
-
Nevanlinna V, Konovalova S, Ceulemans B, Muona M, Laari A, Hilander T, Gorski K, Valanne L, Anttonen AK, Tyynismaa H, Courage C, and Lehesjoki AE
- Subjects
- Alleles, Arginine-tRNA Ligase metabolism, Brain Edema physiopathology, Cerebellum pathology, Epilepsy genetics, Epilepsy physiopathology, Frameshift Mutation, Humans, Infant, Intellectual Disability genetics, Intellectual Disability physiopathology, Magnetic Resonance Imaging, Male, Microcephaly genetics, Muscle Hypotonia blood, Muscle Hypotonia cerebrospinal fluid, Muscle Hypotonia genetics, Muscle Hypotonia physiopathology, Mutation, Missense, Neurodegenerative Diseases physiopathology, Nuclear Proteins genetics, Olivopontocerebellar Atrophies enzymology, Olivopontocerebellar Atrophies physiopathology, Optic Atrophy genetics, Optic Atrophy physiopathology, Phenotype, Seizures genetics, Seizures physiopathology, Spasms, Infantile physiopathology, Transcription Factors genetics, Arginine-tRNA Ligase genetics, Cerebellum diagnostic imaging, Olivopontocerebellar Atrophies diagnosis, Olivopontocerebellar Atrophies genetics
- Abstract
Pontocerebellar hypoplasia type 6 (PCH6) is a rare infantile-onset progressive encephalopathy caused by biallelic mutations in RARS2 that encodes the mitochondrial arginine-tRNA synthetase enzyme (mtArgRS). The clinical presentation overlaps that of PEHO syndrome (Progressive Encephalopathy with edema, Hypsarrhythmia and Optic atrophy). The proband presented with severe intellectual disability, epilepsy with varying seizure types, optic atrophy, axial hypotonia, acquired microcephaly, dysmorphic features and progressive cerebral and cerebellar atrophy and delayed myelination on MRI. The presentation had resemblance to PEHO syndrome but sequencing of ZNHIT3 did not identify pathogenic variants. Subsequent whole genome sequencing revealed novel compound heterozygous variants in RARS2, a missense variant affecting a highly conserved amino acid and a frameshift variant with consequent degradation of the transcript resulting in decreased mtArgRS protein level confirming the diagnosis of PCH6. Features distinguishing the proband's phenotype from PEHO syndrome were later appearance of hypotonia and elevated lactate levels in blood and cerebrospinal fluid. On MRI the proband presented with more severe supratentorial atrophy and lesser degree of abnormal myelination than PEHO syndrome patients. The study highlights the challenges in clinical diagnosis of patients with neonatal and early infantile encephalopathies with overlapping clinical features and brain MRI findings., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
40. Gonadotropin-releasing hormone and kisseptin-10 regulate nuclear receptor subfamily 5 group a member 1/catenin beta 1/ nuclear receptor subfamily 0 group B member 1 activity in female rat anterior pituitary gland.
- Author
-
Zielinska-Gorska M, Gorski K, Biernacka K, Sawosy E, Kaminska T, and Gajewska A
- Subjects
- Animals, DAX-1 Orphan Nuclear Receptor genetics, Female, Gonadotropin-Releasing Hormone antagonists & inhibitors, Kisspeptins antagonists & inhibitors, Pituitary Gland, Anterior metabolism, Rats, Wistar, Steroidogenic Factor 1 genetics, beta Catenin genetics, DAX-1 Orphan Nuclear Receptor metabolism, Gonadotropin-Releasing Hormone pharmacology, Kisspeptins pharmacology, Pituitary Gland, Anterior drug effects, Steroidogenic Factor 1 metabolism, beta Catenin metabolism
- Abstract
In this study, we tested the hypothesis that modulation of endogenous gonadotropin-releasing hormone (Gnrh) neuronal network activity alters the mRNA expression of nuclear receptor subfamily 5 group A member 1 (Nr5a1), through one of the component of Wnt pathway signaling - catenin beta 1 (Ctnnb1) (its co-activator), and its co-repressor nuclear receptor subfamily 0, group B member 1 (Nr0b1) in the female rat pituitary gland in vivo. Adult ovariectomized rats were given a serial infusion of Gnrh, kisspeptin-10, Gnrh + Gnrh antagonist (Antide), or kisspeptin-10 + kisspeptin antagonist (kisspeptin-234) into the third ventricle of the brain. The anterior pituitary and blood was used to mRNA and protein expression analysis. We demonstrated that Gnrh up-regulates Nr5a1 mRNA expression in the anterior pituitary and induces NR5A1 depletion in gonadotropes. Gnrh administration increased both Ctnnb1 mRNA expression and protein synthesis, and induced activation of cellular Ctnnb1 via translocation from the gonadotropes cytoplasm to nucleus. After kisspeptin-10 treatment, up-regulation of Nr0b1 mRNA and protein expression in the anterior pituitary was observed. These data indicate that Gnrh-neuron-mediated network activity alters Nr5a1 gene transcription and translation in gonadotrope cells and this effect may result from the changes induced in the Ctnnb1 and Nr0b1 gene/protein expression balance.
- Published
- 2018
- Full Text
- View/download PDF
41. The impact of H63D HFE gene carriage on hemoglobin and iron status in children.
- Author
-
Barbara KH, Marcin L, Jedrzej A, Wieslaw Z, Elzbieta AD, Malgorzata M, Ewa M, and Jacek KJ
- Subjects
- Adolescent, Child, Female, Humans, Male, Genetic Variation genetics, Hemochromatosis Protein genetics, Hemoglobins metabolism, Heterozygote, Iron blood
- Abstract
The molecular mechanism that regulates iron homeostasis is based on a network of signals, which reflect on the iron requirements of the body. Hereditary hemochromatosis is a heterogenic metabolic syndrome which is due to unchecked transfer of iron into the bloodstream and its toxic effects on parenchymatous organs. It is caused by the mutation of genes that encode proteins that help hepcidin to monitor serum iron. These proteins include the human hemochromatosis protein -HFE, transferrin-receptor 2, hemojuvelin in rare instances, and ferroportin. HFE-related hemochromatosis is the most frequent form of the disease. Interestingly, the low penetrance of polymorphic HFE genes results in rare clinical presentation of the disease, predominantly in middle-aged males. Taking into account the wide dispersion of HFE mutation in our population and also its unknown role in heterozygotes, we analyzed the impact of H63D HFE carriage in the developmental age, with respect to gender, on the iron status and hemoglobin concentration of carriers in comparison to those of wild-type HFE gene (12.7 ± 3.07 years, 42 boys and 41 girls). H63D carriers presented higher blood iron, transferrin saturation, and ferritin concentration than wild-type probands (p < 0.05.) Interestingly, male H63D carriers showed higher hemoglobin concentration than the unburdened children. Moreover, in the H63D carrier group, a positive correlation between iron and hemoglobin was noted. In conclusion, this study demonstrates that changes in iron metabolism occur at a young age in HFE heterozygotes., Competing Interests: The authors declare that they have no conflict of interest.
- Published
- 2016
- Full Text
- View/download PDF
42. Pituitary galaninergic system activity in female rats: the regulatory role of gonadal steroids.
- Author
-
Gajewska A, Zielinska-Gorska M, Wasilewska-Dziubinska E, Baran M, Kotarba G, and Gorski K
- Subjects
- Animals, Estrogen Receptor alpha agonists, Estrogen Receptor beta agonists, Female, Nitriles pharmacology, Ovariectomy, Phenols pharmacology, Pituitary Gland metabolism, Propionates pharmacology, Pyrazoles pharmacology, Rats, Wistar, Estradiol pharmacology, Galanin genetics, Pituitary Gland drug effects, Progesterone pharmacology, Protein Precursors genetics, Receptors, Galanin genetics
- Abstract
The well-recognized sensitivity of the galanin gene in the anterior pituitary gland to estrogen suggests that estrogen receptor activity may influence the galaninergic system through modulation of galanin receptor (GALR) gene expression. Here, we evaluated the following: (i) the effects of estrogen on GALR mRNA expression; (ii) the estrogen receptor subtype that is specifically involved in this activity; and (iii) the effects of progesterone in the absence or presence of estrogen on galanin concentration in anterior pituitary gland. In the first experiment, ovariectomized 4-month-old rats were pre-treated subcutaneously with 17β-estradiol (3 x 20 μg), the ESR1 (ERα) agonist propyl pyrazole triol (PPT) (3 x 5 mg), and the ESR2 (ERβ) agonist diarylpropionitrile (DPN) (3 x 0.5 mg). In the second experiment, 4-month-old ovariectomized females received daily subcutaneous injections of 17β-estradiol (3 x 20 μg), progesterone (2 x 5 mg), or combined estradiol (3 x 20 μg) and progesterone (2 x 5 mg). Anterior pituitaries were excised the day after the final 17β-estradiol injection (experiment I) and 1 hour after receiving the second progesterone dose. Relative GALR1, GALR2, and GALR3 mRNA expression was evaluated using quantitative real-time PCR, and pituitary galanin concentration was determined using a specific radioimmunoassay. The results revealed that estrogen predominantly induced a 5-fold increase in GALR3 gene transcription. To a lesser extent, 17β-estradiol also increased GALR1 mRNA expression, but had no effect on GALR2 mRNA levels. The estrogen-induced increase in GALR3 gene expression occurred exclusively through ESR1 activation. The increase in GALR1 gene expression occurred through activation of both estrogen receptor subtypes, but the ESR2 subtype was predominantly involved. Furthermore, the results revealed that progesterone regulates the activity of the pituitary galaninergic system by facilitating estradiol-induced galanin synthesis in the female rat anterior pituitary gland.
- Published
- 2016
43. Locomotor Training in the Pediatric Spinal Cord Injury Population: A Systematic Review of the Literature.
- Author
-
Gorski K, Harbold K, Haverstick K, Schultz E, Shealy SE, and Krisa L
- Abstract
Background: The restoration of walking ability in the spinal cord injury (SCI) population is an increasingly important goal in physical therapy. Locomotor training (LT) is often implemented with the aim to restore ambulation. At this point, there are no guidelines for LT in the pediatric SCI population. Objectives: The aim of this review is to further narrow the effects of LT to the pediatric SCI population and develop recommendations for pediatric LT. Methods: A thorough search was performed using the following databases: Scopus, CINAHL, PubMed, and Ovid. Studies were selected based on the following inclusion criteria: pediatric SCI population, articles published within last 10 years, human subjects, and LT. Studies looking at other neurological disorders and subjects who were not previously ambulatory were excluded. Five students and one Faculty Research Advisor from the university's Doctor of Physical Therapy Program evaluated the inclusion criteria, conducted a risk of bias assessment using the Downs and Black checklist, and extracted the results. Results: Six studies were selected for this review. They showed gains in distance, gait speed, walking independence, and participation. There were variations in results when comparing gains in injury level based on the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). Conclusions: Currently there is insufficient evidence to determine the best clinical practice guidelines for rehabilitation using LT within the pediatric SCI population.
- Published
- 2016
- Full Text
- View/download PDF
44. Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies using Fak-deficient mice.
- Author
-
Roh ME, Cosgrove M, Gorski K, and Hitchcock IS
- Subjects
- Animals, Focal Adhesion Protein-Tyrosine Kinases genetics, Mice, Mice, Knockout, Focal Adhesion Protein-Tyrosine Kinases antagonists & inhibitors, Platelet Activation drug effects, Protein Kinase Inhibitors pharmacology
- Published
- 2013
- Full Text
- View/download PDF
45. The clinical utility of functional performance tests within one-year post-acl reconstruction: a systematic review.
- Author
-
Narducci E, Waltz A, Gorski K, Leppla L, and Donaldson M
- Abstract
Introduction: A tear of the anterior cruciate ligament (ACL) represents a significant injury for an athlete that requires substantial time away from sport, and significant rehabilitation after reconstruction. The physical therapist is responsible to determine when a patient is capable of tolerating the physical demands of daily activities and to attempt to prevent re-injury. Physical or functional performance tests (FPTs) are one mechanism used to evaluate the athlete's physical skills and capabilities prior to returning to sports participation. The purpose of this systematic review is to critically examine the clinical utility of functional performance tests used with patients less than or equal to one year post ACL reconstruction., Methods: A systematic review of the relevant literature was performed using PRISMA guidelines. A total of twelve studies were included for analysis., Results: Two independent blinded reviewers then analyzed and rated the final included articles (n=12) utilizing the Newcastle-Ottawa Scale (NOS). Percent overall agreement between raters for the NOS was 88% with a fixed-marginal kappa (κ) of 0.80. Of the 12 included articles, the FPTs were utilized as an outcome measure within the study design (41.7%) or studied as a measure of function (58.3%). Among those studies that used FPTs as a "measure of function" 71.4% studied a battery of FPTs, while 28.6% studied a single test. None of the studies utilized FPTs as a measure to determine readiness to return to sport., Discussion: FPTs are being utilized with patients, less than or equal to one year post ACL reconstruction, either as an assessment of functional performance or as an outcome measure. No studies identified a FPT or test battery that has construct or predictive validity for "return to sport" in athletic population one-year post-ACL reconstruction. The identification of the critical elements within the return to sport construct may allow lower extremity performance tests to be developed or test batteries assembled to incorporate the appropriate tests to examine all of these elements deemed critical. Additionally the current FPTs should undergo content and predictive validation to assist the sports physical therapist in determining the readiness of the athlete for return to sport.
- Published
- 2011
46. Out of time and out of pocket: experiences of women seeking state-subsidized insurance for abortion care in Massachusetts.
- Author
-
Bessett D, Gorski K, Jinadasa D, Ostrow M, and Peterson MJ
- Subjects
- Abortion, Induced statistics & numerical data, Adult, Female, Follow-Up Studies, Health Services Accessibility, Humans, Income, Massachusetts, Pregnancy, Pregnancy Outcome, Qualitative Research, Referral and Consultation statistics & numerical data, Reproductive Health Services organization & administration, Socioeconomic Factors, Time Factors, Young Adult, Abortion Applicants, Abortion, Induced economics, Health Knowledge, Attitudes, Practice, Insurance, Health statistics & numerical data, Reproductive Health Services statistics & numerical data
- Abstract
Background: Massachusetts has implemented reforms aimed at providing universal health care coverage and covers abortion through subsidized state insurance programs. Three Massachusetts abortion funds evaluated their referral processes for low-income women from April to October 2010 to learn about women's experiences applying for subsidized insurance and to identify barriers to obtaining insurance or its use for abortion services., Methods: Follow-up interviews were conducted with 39 low-income women thought eligible for subsidized insurance at least 1 month after their initial contact with the funds., Results: Health insurance literacy was low, and participants reported confusion distinguishing between levels of subsidized insurance. The process of applying for subsidized insurance delayed a substantial proportion of procedures. More than two thirds of the women who applied for state coverage had become insured or expected to become insured shortly, but only one third of respondents who applied were able to secure insurance in time for their abortion care. Two women were unable to obtain abortions as a result of delays. Delays also limited low-income women's ability to obtain medication abortion., Conclusion: This analysis suggests that the process for enrolling in subsidized insurance does not currently meet the goal of providing women with coverage for abortion care (and other health needs) in a timely way. Systemic improvements are needed to ensure that enrollments are processed quickly and disruptions in coverage are minimized. Information resources should be developed to help women and their families understand health insurance and coverage of services., (Copyright © 2011 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
47. Anesthesia in the obese.
- Author
-
Lebuffe G, Andrieu G, Wierre F, Gorski K, Sanders V, Chalons N, and Vallet B
- Subjects
- Anastomotic Leak etiology, Anesthesia adverse effects, Anesthetics adverse effects, Body Mass Index, Cardiovascular Diseases etiology, Humans, Intubation, Intratracheal methods, Obesity surgery, Oxygen administration & dosage, Peripheral Nerve Injuries, Postoperative Care, Preoperative Care, Rhabdomyolysis etiology, Surgical Wound Infection etiology, Treatment Outcome, Anesthesia methods, Anesthetics administration & dosage, Bariatric Surgery, Obesity, Morbid surgery
- Published
- 2010
- Full Text
- View/download PDF
48. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor.
- Author
-
Shin T, Kennedy G, Gorski K, Tsuchiya H, Koseki H, Azuma M, Yagita H, Chen L, Powell J, Pardoll D, and Housseau F
- Subjects
- Animals, Apoptosis Regulatory Proteins, B7-2 Antigen, Lymphocyte Activation, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Programmed Cell Death 1 Ligand 2 Protein, Programmed Cell Death 1 Receptor, Antigens, CD physiology, Antigens, Surface physiology, B7-1 Antigen physiology, CD4-Positive T-Lymphocytes immunology, Membrane Glycoproteins physiology
- Abstract
B7-DC is a recently discovered member of the B7 family that binds to PD-1 and is selectively expressed by dendritic cells (DCs). It has been shown to either costimulate or inhibit T cell responses. To assess the role of B7-DC in DC-T cell interactions, DCs from B7-DC knockout (KO) mice were generated and compared with DCs from wild-type (WT) and B7-1/B7-2 double KO mice. B7-1/B7-2-deficient DCs, while strongly diminished in their ability to stimulate naive CD4+ T cells, nonetheless retain partial activity. DCs from B7-DC KO mice are diminished in their ability to activate CD4+ T cells, demonstrating that DC-expressed B7-DC serves a predominantly stimulatory rather than inhibitory function in the initiation of T cell responses. B7-DC costimulates expression of CD40L with faster kinetics than B7-1 and displays potent synergy with B7-1 and B7-2 for T cell proliferation and cytokine production, indicating that these B7 family members work in concert to stimulate T cells. Finally, costimulation with B7-DC alone or in conjunction with B7-1 is PD-1 independent, indicating that B7-DC costimulates T cells via a second receptor.
- Published
- 2003
- Full Text
- View/download PDF
49. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells.
- Author
-
Cui Y, Kelleher E, Straley E, Fuchs E, Gorski K, Levitsky H, Borrello I, Civin CI, Schoenberger SP, Cheng L, Pardoll DM, and Whartenby KA
- Subjects
- Animals, Antigens metabolism, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes metabolism, CD40 Antigens genetics, CD40 Antigens immunology, CD40 Antigens metabolism, CD8-Positive T-Lymphocytes physiology, Cells, Cultured, Dendritic Cells physiology, Hemagglutination genetics, Hematopoietic Stem Cells physiology, Interferon-gamma metabolism, Lentivirus genetics, Lymphoma, B-Cell genetics, Mice, Mice, Inbred BALB C, Neoplasms, Experimental genetics, Spleen cytology, Survival Rate, T-Lymphocytes immunology, T-Lymphocytes physiology, Transduction, Genetic, Transplantation, Autologous, Bone Marrow Transplantation methods, Hematopoietic Stem Cell Transplantation methods, Immunotherapy, Adoptive methods, Lymphoma, B-Cell immunology, Lymphoma, B-Cell therapy, Neoplasms, Experimental immunology, Neoplasms, Experimental therapy
- Abstract
A major focus of cancer immunotherapy is to develop strategies to induce T-cell responses through presentation of tumor antigens by dendritic cells (DCs). Current vaccines are limited in their ability to efficiently transfer antigens to DCs in vivo. Ex vivo-generated DCs can be efficiently loaded with antigen but after reinjection, few DCs traffic to secondary lymphoid organs, the critical sites for antigen presentation. To enhance efficiency and durability of antigen presentation by DCs, we transduced hematopoietic stem-progenitor cells (HSCs) with a model tumor antigen and then transplanted the gene-modified cells into irradiated recipient mice, which resulted in efficient expression of the transgene in a large proportion of donor derived DCs in lymphoid organs. The combination of bone marrow transplantation (BMT) using transduced HSCs, systemic agents that generate and activate DCs, and mature T-cell infusion resulted in substantial expansion and activation of antigen-specific T cells. This tripartite strategy provided potent antigen-specific immunotherapy for an aggressive established tumor.
- Published
- 2003
- Full Text
- View/download PDF
50. An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin.
- Author
-
Golgher D, Korangy F, Gao B, Gorski K, Jaffee E, Edidin M, Pardoll DM, and Elliott T
- Subjects
- Animals, Antigens, Neoplasm chemistry, CD4-Positive T-Lymphocytes immunology, Calreticulin, Endoplasmic Reticulum immunology, Epitopes, T-Lymphocyte immunology, Female, Gene Products, env metabolism, Hot Temperature, Hybridomas metabolism, Leukemia Virus, Murine immunology, Lymphocyte Activation, Mice, Mice, Inbred BALB C, Mice, SCID, Mice, Transgenic, Protein Binding immunology, Protein Conformation, Protein Denaturation, Tumor Cells, Cultured, Antigens, Neoplasm metabolism, Calcium-Binding Proteins metabolism, Endoplasmic Reticulum metabolism, Histocompatibility Antigens Class II metabolism, Immunodominant Epitopes metabolism, Ribonucleoproteins metabolism
- Abstract
There is accumulating evidence that CD4(+) T cell responses are important in antitumor immunity. Accordingly, we generated CD4(+) T cells against the murine CT26 colon cancer. Three of three independent CT26-specific CD4(+) hybridomas were found to recognize the high m.w. precursor of the env gene product gp90. The CD4(+) response was completely tumor specific in that the same glycoprotein expressed by other tumors was not recognized by the CT26-specific hybridomas. The recognition of gp90 by the hybridomas was strictly dependent on the conformation of gp90. Different procedures that disrupted the conformation of the glycoprotein, such as disulfide bond reduction and thermal denaturation, completely abrogated recognition of gp90 by all three hybridomas. In CT26 cells, but not in other tumor cells tested, a large proportion of gp90 was retained in the endoplasmic reticulum, mostly bound to the endoplasmic reticulum chaperone, calreticulin. Although calreticulin was not essential for the stimulation of the gp90-specific hybridomas, most of the antigenic form of gp90 was bound to it. The antigenicity of gp90 correlated well with calreticulin binding, reflecting the fact that specificity of binding of calreticulin to its substrate required posttranslational modifications that were also necessary for the generation of this tumor-specific CD4(+) epitope.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.